FDA Panel Votes for Limits on Some GI Cancer Immunotherapy ...Middle East

After hours of company pushback, FDA's Oncologic Drugs Advisory Committee voted that the benefit of immunotherapy in low or no PD-L1 expressors doesn't outweigh the risks. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Panel Votes for Limits on Some GI Cancer Immunotherapy )

Also on site :

• Morning Report — Texas braces for more flood danger after Hill Country tragedy 
• Bangladesh lawyers challenge ex-PM Hasina’s murder trial charges
• Ukraine plagued by ‘palace politics’ and purges – Economist